16 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... Guideline for the Management ... Task Force on Clinical ... #HeartFailure #Management ... #treatment #algorithm
Nontuberculous mycobacteria
Nontuberculous mycobacteria, also known as atypical mycobacteria, are all the other mycobacteria which can cause
mycobacteria, are all ... mycobacteria which can cause ... pulmonary disease ... #Clinical #Radiology ... AirFluidLevel #RadiologyAssistant
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... Treat underlying cause ... Treat underlying cause ... #management #cardiology ... #algorithm
Interventional bronchoscopic and surgical treatments for chronic obstructive pulmonary disease (COPD). Overview of various therapies used
bronchoscopic and surgical treatments ... chronic obstructive pulmonary ... are approved for clinical ... #Management #AdvancedCOPD ... VolumeReduction #Bullectomy #Algorithm
Myasthenia Gravis - Summary
 • an autoimmune disease of the postsynaptic neuromuscular junction associated with antibodies
Diagnosis: • Based on clinical ... More likely to cause ... glucocorticoids - can cause ... - Improves clinical ... Gravis #diagnosis #management
Hydroxyapatite Deposition Disease (HADD) - MSK Radiology
Imaging Findings:
 • Ovoid hypointense structures along the bursal surface
Disease (HADD) - MSK ... Case description ... low-signal on all ... • Treatment for ... #msk
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... the determined cause ... #differential #algorithm ... #management #cardiology ... #treatment #table
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
exclude other causes ... cardiomyopathy • Pulmonary ... Clinical • Under-recognized ... support for patients clinically ... #cardiology #treatment
Pulmonary Nodule
Evaluation is guided by nodule size & assessment of probability of malignancy. In addition is
are called lung masses ... malignancy is < 1% for all ... lung malignancy, clinical ... The treatment of ... Management options
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... algorithm to determine ... Change in clinical ... one post op Cardiology ... medical and surgical management